Bright Green To Supply DEA-Approved Cannabis Extracts And Psychedelics To FDA-Registered Pharmaceutical Company
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 22 2024
0mins
Source: Benzinga
Bright Green Corporation's Supply Agreement: Bright Green Corporation has signed a letter of intent to supply DEA-approved cannabis extracts and plant-based psychedelics to Benuvia Operations, which is FDA-registered and DEA-licensed, for clinical use in pharmaceutical manufacturing.
Regulatory Approvals and Future Plans: The company has received final approval from the New Mexico Board of Pharmacy and the DEA for Schedule I and II substances, positioning itself as a leading supplier of plant-based raw materials for cannabinoid, psychedelic, and opioid-based drugs in the U.S. market.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
